Mass vaccination has the potential to curb the current COVID-19 pandemic by protecting
individuals who have been vaccinated against the disease and possibly lowering the …

Beyond their substantial protection of individual vaccinees, coronavirus disease 2019
(COVID-19) vaccines might reduce viral load in breakthrough infection and thereby further …

Infectious viral load (VL) expelled as droplets and aerosols by infected individuals partly
determines transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Beyond their substantial protection of individual vaccinees, it is hoped that the COVID-19
vaccines would reduce viral load in breakthrough infections thereby further suppress …

Studies on the real-life effect of the BNT162b2 vaccine for Coronavirus Disease 2019
(COVID-19) prevention are urgently needed. In this study, we conducted a retrospective …

Worldwide shortage of vaccination against SARS-CoV-2 infection while the pandemic is still
uncontrolled leads many states to the dilemma whether or not to vaccinate previously …

Vaccination, especially with multiple doses, provides substantial population-level protection
against COVID-19, but emerging variants of concern (VOC) and waning immunity represent …

The BNT162b2 mRNA COVID-19 vaccine (Pfizer-BioNTech) is being utilised internationally
for mass COVID-19 vaccination. Evidence of single-dose protection against symptomatic …

Recent studies have provided key information about SARS-CoV-2 vaccines' efficacy and
effectiveness (VE). One important question that remains is whether the protection conferred …

To the Editor—Public-health interventions aimed at curbing the spread of the coronavirus
SARS-CoV-2 have been limited to non-pharmaceutical interventions, including travel …